The proportion of subjects who experienced more than 10 letters improvement of visual acuity in ETDRS chart from baseline to week 24 was statistically significantly greater ( p-value = 0.0003 ) in the pegaptanib sodium group , 20.3 % , than in the sham group , 5.0 % .